{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:45:09Z","timestamp":1791521109323,"version":"4.3.4"},"reference-count":90,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Endovasc Ther"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Chronic iliofemoral venous obstruction (CIVO) is primarily caused by nonthrombotic iliac vein lesions (NIVLs) and postthrombotic syndrome (PTS). Iliac vein stenting (IVS) is widely used for symptomatic CIVO, but outcomes across etiologies have not been comprehensively synthesized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a single-arm systematic review and meta-analysis of 5 electronic databases through August 21, 2025. Studies evaluating IVS for CIVO were included. Primary outcomes were primary and secondary stent patency and changes in clinical scores (venous clinical severity score, revised VCSS, Villalta). Secondary outcomes included ulcer healing, symptom resolution, and major adverse events (MAEs). Subgroup analyses were conducted by etiology (PTS vs NIVL). This systematic review was registered in the PROSPERO database (registration number: CRD420251206932).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-seven studies involving 6769 patients were included. Pooled mid-term (12\u201324 months) primary and secondary patency rates were 82% and 93%, respectively, and long-term (&gt;24 months) rates were 75% and 91%, respectively. Pooled mid-term primary patency was 97% (95% confidence interval [CI]: 96%\u201399%) for NIVL versus 77% (95% CI: 70%\u201383%) for PTS (p&lt;0.001). Long-term primary patency remained high in NIVL at 97% (95% CI: 95%\u2013100%) but was significantly lower in PTS at 70% (95% CI: 65%\u201376%). Clinical scores improved after intervention. The median ulcer healing rate was 75%. The incidence of MAEs was higher in PTS than in NIVL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Iliac vein stenting is associated with favorable patency and clinical improvement in CIVO. Outcomes were consistently better in NIVL than in PTS, with lower long-term patency and higher MAEs in PTS. Future studies should focus on optimizing poststenting antithrombotic strategies and improving long-term outcomes, particularly in PTS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Impact<\/jats:title>\n                    <jats:p>This study provides a comprehensive meta-analysis quantifying the impact of etiology, IVUS guidance, and anti-coagulation duration on iliac vein stenting outcomes. The primary innovation lies in the evidence-based differentiation between non-thrombotic lesions (NIVL) and post-thrombotic syndrome (PTS). For clinicians, these findings necessitate etiology-specific management: while NIVL achieves high patency with short-term therapy, PTS requires meticulous procedural optimization (IVUS) and significantly benefits from extended anticoagulation for long-term durability (78% vs. 64%, p = 0.046). These insights drive a shift toward individualized post-stenting protocols, improving patient selection and long-term clinical success in chronic obstructive venous disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15266028261453257","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:46:25Z","timestamp":1780469185000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Iliac Vein Stenting in Patients With Different Etiologies of Chronic Iliofemoral Venous Obstruction: A Single-Arm Systematic Review and Meta-Analysis"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-2301","authenticated-orcid":false,"given":"Hong-Jie","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Vascular Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, China"},{"name":"Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Feng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Vascular Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","unstructured":"Cockett FB Thomas ML. The iliac compression syndrome. Br J Surg. 1965;52(10):816\u2013821. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=5828716&query_hl=1. doi: 10.1002\/bjs.1800521028.","DOI":"10.1002\/bjs.1800521028"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","unstructured":"Poyyamoli S Mehta P Cherian M et al. May-Thurner syndrome. Cardiovasc Diagn Ther. 2021;11(5):1104\u20131111. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34815961&query_hl=1. doi: 10.21037\/cdt.2020.03.07.","DOI":"10.21037\/cdt.2020.03.07"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","unstructured":"May R Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology.1957;8(5):419\u2013427. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=13478912&query_hl=1. doi: 10.1177\/000331975700800505.","DOI":"10.1177\/000331975700800505"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","unstructured":"Chaitidis N Kokkinidis DG Papadopoulou Z Hasemaki N Attaran R Bakoyiannis C. Management of post-thrombotic syndrome: a comprehensive review. Curr Pharm Des. 2022;28(7):550\u2013559. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35100955&query_hl=1. doi: 10.2174\/1381612828666220131094655.","DOI":"10.2174\/1381612828666220131094655"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","unstructured":"De Maeseneer MG Kakkos SK Aherne T et al. Editor\u2019s choice \u2013 European society for vascular surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg. 2022;63(2):184\u2013267. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35027279&query_hl=1. doi: 10.1016\/j.ejvs.2021.12.024.","DOI":"10.1016\/j.ejvs.2021.12.024"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","unstructured":"Taha MA Busuttil A Bootun R et al. Clinical outcomes and overview of dedicated venous stents for management of chronic iliocaval and femoral deep venous disease. Vascular. 2022;30(2):320\u2013330. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33813974&query_hl=1. doi: 10.1177\/1708538121989860.","DOI":"10.1177\/1708538121989860"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","unstructured":"Shamimi-Noori SM Clark TWI. Venous stents: current status and future directions. Tech Vasc Interv Radiol. 2018;21(2):113\u2013116. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29784119&query_hl=1. doi: 10.1053\/j.tvir.2018.03.007.","DOI":"10.1053\/j.tvir.2018.03.007"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","unstructured":"Badesha AS Black SA Khan G et al. A meta-analysis of the medium- to long-term outcomes in patients with chronic deep venous disease treated with dedicated venous stents. J Vasc Surg Venous Lymphat Disord. 2024;12(3):101722. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=38104855&query_hl=1. doi: 10.1016\/j.jvsv.2023.101722.","DOI":"10.1016\/j.jvsv.2023.101722"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","unstructured":"Passman MA McLafferty RB Lentz MF et al. Validation of venous clinical severity score (VCSS) with other venous severity assessment tools from the American venous forum national venous screening program. J Vasc Surg. 2011;54(6 Suppl):2S\u20139S. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21962926&query_hl=1. doi: 10.1016\/j.jvs.2011.05.117.","DOI":"10.1016\/j.jvs.2011.05.117"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","unstructured":"Vasquez MA Rabe E McLafferty RB et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American venous forum ad hoc outcomes working group. J Vasc Surg. 2010;52(5):1387\u20131396. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=20875713&query_hl=1. doi: 10.1016\/j.jvs.2010.06.161.","DOI":"10.1016\/j.jvs.2010.06.161"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","unstructured":"Lattimer CR Kalodiki E Azzam M Geroulakos G. Validation of the villalta scale in assessing post-thrombotic syndrome using clinical duplex and hemodynamic comparators. J Vasc Surg Venous Lymphat Disord.2014;2(1):8\u201314. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26992962&query_hl=1. doi: 10.1016\/j.jvsv.2013.06.003.","DOI":"10.1016\/j.jvsv.2013.06.003"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","unstructured":"Rutherford RB Baker JD Ernst C et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517\u2013538. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9308598&query_hl=1. doi: 10.1016\/s0741-5214(97)70045-4.","DOI":"10.1016\/s0741-5214(97)70045-4"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","unstructured":"Launois R Reboul-Marty J Henry B. Construction and validation of a quality of life questionnaire in chronic lower limb venous insufficiency (CIVIQ). Qual Life Res. 1996;5(6):539\u2013554. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8993100&query_hl=1. doi: 10.1007\/BF00439228.","DOI":"10.1007\/BF00439228"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","unstructured":"Kahn SR Lamping DL Ducruet T et al. VEINES-QOL\/sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis. J Clin Epidemiol. 2006;59(10):1049\u20131056. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16980144&query_hl=1. doi: 10.1016\/j.jclinepi.2005.10.016.","DOI":"10.1016\/j.jclinepi.2005.10.016"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","unstructured":"Sterne JA Hern\u00e1n MA Reeves BC et al. ROBINS-i: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;12355:i4919. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=27733354&query_hl=1. doi: 10.1136\/bmj.i4919.","DOI":"10.1136\/bmj.i4919"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","unstructured":"Slim K Nini E Forestier D Kwiatkowski F Panis Y Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u2013716. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12956787&query_hl=1. doi: 10.1046\/j.1445-2197.2003.02748.x.","DOI":"10.1046\/j.1445-2197.2003.02748.x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","unstructured":"Sterne JAC Savovi\u0107 J Page MJ et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28366:l4898. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31462531&query_hl=1. doi: 10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","unstructured":"Guyatt GH Oxman AD Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;26336(7650):924\u2013926. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=18436948&query_hl=1. doi: 10.1136\/bmj.39489.470347.AD.","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","unstructured":"Barker TH Migliavaca CB Stein C et al. Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence. BMC Med Res Methodol. 2021;2021(1):189. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34544368&query_hl=1. doi: 10.1186\/s12874-021-01381-z.","DOI":"10.1186\/s12874-021-01381-z"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","unstructured":"Higgins JPT Thompson SG Deeks JJ Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;6327(7414):557\u2013560. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12958120&query_hl=1. doi: 10.1136\/bmj.327.7414.557.","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","unstructured":"Moini M Zafarghandi MR Taghavi M et al. Venoplasty and stenting in post-thrombotic syndrome and non-thrombotic iliac vein lesion. Minim Invasive Ther Allied Technol. 2020;29(1):35\u201341. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30794000&query_hl=1. doi: 10.1080\/13645706.2019.1580748.","DOI":"10.1080\/13645706.2019.1580748"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","unstructured":"Salem AM AboElNeel HA Fakhr ME. Long-term outcome of dedicated venous stents in management of chronic iliofemoral obstruction. J Vasc Surg Venous Lymphat Disord. 2022;10(1):52\u201359. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34020109&query_hl=1. doi: 10.1016\/j.jvsv.2021.04.018.","DOI":"10.1016\/j.jvsv.2021.04.018"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","unstructured":"Razavi MK Gagne P Black S et al. Midterm and long-term outcomes following dedicated endovenous nitinol stent placement for symptomatic iliofemoral venous obstruction: three- to 5-year results of the VIRTUS study. J Vasc Interv Radiol. 2022;33(12):1485\u20131491. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=36067976&query_hl=1. doi: 10.1016\/j.jvir.2022.08.028.","DOI":"10.1016\/j.jvir.2022.08.028"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","unstructured":"Murphy E Gibson K Sapoval M et al. Pivotal study evaluating the safety and effectiveness of the abre venous self-expanding stent system in patients with symptomatic iliofemoral venous outflow obstruction. Circ Cardiovasc Interv. 2022;15(2):e010960. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35105153&query_hl=1. doi: 10.1161\/CIRCINTERVENTIONS.121.010960.","DOI":"10.1161\/CIRCINTERVENTIONS.121.010960"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","unstructured":"Stuck AK Reich T Engelberger RP Sebastian T Kucher N. Endovascular treatment of post-thrombotic and non-thrombotic iliofemoral venous outflow obstructions with self-expanding nitinol stents. VASA. 2018;47(4):319\u2013325. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29512422&query_hl=1. doi: 10.1024\/0301-1526\/a000697.","DOI":"10.1024\/0301-1526\/a000697"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","unstructured":"Stuck AK Kunz S Baumgartner I Kucher N. Patency and clinical outcomes of a dedicated self-expanding hybrid oblique stent used in the treatment of common iliac vein compression. J Endovasc Ther. 2017;24(1):159\u2013166. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=27831483&query_hl=1. doi: 10.1177\/1526602816676803.","DOI":"10.1177\/1526602816676803"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","unstructured":"Tang TY Lim MH Damodharan K et al. Use of the VENOVO\u2122 and sinus obliquus\u2122 venous stents in the treatment of non-thrombotic or post-thrombotic iliac vein lesions\u2013short-term results from a multi-centre Asian cohort. Phlebology. 2021;36(1):70\u201378. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=32811290&query_hl=1. doi: 10.1177\/0268355520946219.","DOI":"10.1177\/0268355520946219"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","unstructured":"Razavi M Lichtenberg M Desai K et al. The VIVID trial 12-month outcomes of the venous stent for the iliofemoral vein using the duo venous stent system. J Vasc Surg Venous Lymphat Disord. 2025;13(2):101995. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=39477150&query_hl=1. doi: 10.1016\/j.jvsv.2024.101995.","DOI":"10.1016\/j.jvsv.2024.101995"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","unstructured":"Lichtenberg MKW Stahlhoff WF Stahlhoff S \u00d6zkapi A Breuckmann F de Graaf R. Venovo venous stent for treatment of non-thrombotic or post-thrombotic iliac vein lesions \u2013 long-term efficacy and safety results from the Arnsberg Venous Registry. VASA. 2021;50(1):52\u201358. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=32697148&query_hl=1. doi: 10.1024\/0301-1526\/a000893.","DOI":"10.1024\/0301-1526\/a000893"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","unstructured":"Lichtenberg M Stahlhoff S \u00d6zkapi A de Graaf R. Braided nitinol stent for chronic iliofemoral venous disease \u2013 the real-world BLUEFLOW registry. VASA. 2021;50(5):372\u2013377. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33955794&query_hl=1. doi: 10.1024\/0301-1526\/a000953.","DOI":"10.1024\/0301-1526\/a000953"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","unstructured":"Lichtenberg M Breuckmann F Stahlhoff WF Negl\u00e9n P Rick DG. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions\u2013short-term safety patency and clinical outcomes. VASA. 2018;47(6):475\u2013481. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30175948&query_hl=1. doi: 10.1024\/0301-1526\/a000731.","DOI":"10.1024\/0301-1526\/a000731"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","unstructured":"Lichtenberg M de Graaf R Stahlhoff WF \u00d6zkapi A Simon M Breuckmann F. Patency rates safety and clinical results of the sinus-obliquus venous stent in the treatment of chronic ilio-femoral venous outflow obstruction \u2013 data from the Arnsberg Venous Registry. VASA. 2019;48(3):270\u2013275. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30526435&query_hl=1. doi: 10.1024\/0301-1526\/a000772.","DOI":"10.1024\/0301-1526\/a000772"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","unstructured":"Ignatyev IM Pokrovsky A Gradusov E. Long-term results of endovascular treatment of chronic iliofemoral venous obstructive lesions. Vasc Endovascular Surg. 2019;53(5):373\u2013378. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30935347&query_hl=1. doi: 10.1177\/1538574419839256.","DOI":"10.1177\/1538574419839256"},{"key":"e_1_3_3_35_2","doi-asserted-by":"crossref","unstructured":"Lim MNHH Damodharan K Chan SL Toh MR Yap CJQ Chong TT et al. Endovascular deep vein stenting of symptomatic post-thrombotic and non-thrombotic iliac vein stenotic lesions: a multicentre cohort experience from Singapore. Ann Acad Med Singap. 2020;49(8):551\u2013560. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33164025&query_hl=1","DOI":"10.47102\/annals-acadmedsg.2019253"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","unstructured":"Comerota AJ Gagne P Brown JA Segbefia E Hofmann LV. Final 3-year study outcomes from the evaluation of the Zilver Vena Venous Stent for the treatment of symptomatic iliofemoral venous outflow obstruction (the VIVO clinical study). J Vasc Interv Radiol. 2024;35(6):834\u2013845. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=38484910&query_hl=1. doi: 10.1016\/j.jvir.2024.02.025.","DOI":"10.1016\/j.jvir.2024.02.025"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","unstructured":"Jalaie H Barbati ME Piao L et al. Prognostic value of a classification system for iliofemoral stenting in patients with chronic venous obstruction. Eur J Vasc Endovasc Surg. 2025;69(2):315\u2013322. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=39393577&query_hl=1. doi: 10.1016\/j.ejvs.2024.10.002.","DOI":"10.1016\/j.ejvs.2024.10.002"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","unstructured":"Tosenovsky P Vlaskovsky P. Quality of life after stenting for chronic iliocaval obstruction. Phlebology. 2022;37(6):469\u2013475. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35440243&query_hl=1. doi: 10.1177\/02683555221089614.","DOI":"10.1177\/02683555221089614"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","unstructured":"Ortega MR Tejero OT Benages EM Griggs A Segbefia E Mallagray EP. Real-world outcomes of Zilver Vena\u00ae venous self expanding stent placement for thrombotic and non-thrombotic indications in Spain. Phlebology. 2025;40(7):496\u2013507. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=39868739&query_hl=1. doi: 10.1177\/02683555251316413.","DOI":"10.1177\/02683555251316413"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","unstructured":"Elshafei S Schleimer K Gombert A Jalaie H Barbati ME. Effect of stent shape in areas of high compression on patency rates after venous recanalization in patients with chronic venous obstruction. Int Angiol. 2025;44(1):6\u201313. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=40172318&query_hl=1. doi: 10.23736\/S0392-9590.25.05298-8.","DOI":"10.23736\/S0392-9590.25.05298-8"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","unstructured":"Black S Gwozdz A Karunanithy N et al. Two year outcome after chronic iliac vein occlusion recanalisation using the Vici Venous Stent(\u00ae). Eur J Vasc Endovasc Surg. 2018;56(5):710\u2013718. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30139572&query_hl=1. doi: 10.1016\/j.ejvs.2018.07.014.","DOI":"10.1016\/j.ejvs.2018.07.014"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","unstructured":"Sarici IS Yanar F Agcaoglu O et al. Our early experience with iliofemoral vein stenting in patients with post-thrombotic syndrome. Phlebology. 2014;29(5):298\u2013303. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=23512690&query_hl=1. doi: 10.1177\/0268355513477641.","DOI":"10.1177\/0268355513477641"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","unstructured":"David A Thony F Del Giudice C et al. Short- and mid-term outcomes of endovascular stenting for the treatment of post-thrombotic syndrome due to iliofemoral and caval occlusive disease: a multi-centric study from the french society of diagnostic and interventional cardiovascular imaging (SFICV). Cardiovasc Intervent Radiol. 2022;45(2):162\u2013171. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34981196&query_hl=1. doi: 10.1007\/s00270-021-03038-2.","DOI":"10.1007\/s00270-021-03038-2"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","unstructured":"Chen R Feng R Jiang S et al. Stent patency rates and prognostic factors of endovascular intervention for iliofemoral vein occlusion in post-thrombotic syndrome. BMC Surg. 2022;1222(1):269. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35831845&query_hl=1. doi: 10.1186\/s12893-022-01714-9.","DOI":"10.1186\/s12893-022-01714-9"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","unstructured":"Marcelin C Thouveny F Goyault G et al. Ilio-femoral venous stenting for post-thrombotic syndrome in women of childbearing age: efficacy and impact of pregnancy-a multi-center study by the French society of cardiovascular imaging. Eur Radiol. 2024;34(3):1567\u20131577. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=37653047&query_hl=1. doi: 10.1007\/s00330-023-10188-z.","DOI":"10.1007\/s00330-023-10188-z"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","unstructured":"Atalla K Elkady M Khalil MS Mahmoud O Shahat M. Addressing the impact of deep venous stenting on the management of venous ulcer. Ann Vasc Surg. 2024;105:265\u2013274. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=38599493&query_hl=1. doi: 10.1016\/j.avsg.2024.02.021.","DOI":"10.1016\/j.avsg.2024.02.021"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","unstructured":"Bakas JM de Wolf MAF van den Bos RR et al. Venous stents placed for postthrombotic syndrome: the role of inflow disease on patency. J Vasc Interv Radiol. 2025;36(3):446\u2013455. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=39662620&query_hl=1. doi: 10.1016\/j.jvir.2024.11.030.","DOI":"10.1016\/j.jvir.2024.11.030"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","unstructured":"Espitia O Douane F Hersant J et al. Predictive factors of stent patency in iliofemoral venous diseases in a multicentre cohort study. Eur J Vasc Endovasc Surg. 2023;65(4):564\u2013572. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=36642400&query_hl=1. doi: 10.1016\/j.ejvs.2023.01.005.","DOI":"10.1016\/j.ejvs.2023.01.005"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","unstructured":"Gautier G Douane F David A et al. Pharmaco-mechanical catheter-directed thrombolysis versus recanalization and stenting for post thrombotic syndrome after lower limb deep vein thrombosis: a comparative study. Quant Imaging Med Surg. 2022;12(3):1664\u20131673. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35284255&query_hl=1. doi: 10.21037\/qims-21-572.","DOI":"10.21037\/qims-21-572"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","unstructured":"van Vuuren TMAJ de Wolf MAF Arnoldussen CWKP Kurstjens RLM van Laanen JHH Jalaie H et al. Editor\u2019s choice\u2013reconstruction of the femoro-ilio-caval outflow by percutaneous and hybrid interventions in symptomatic deep venous obstruction. Eur J Vasc Endovasc Surg. 2017;54(4):495\u2013503. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28778457&query_hl=1. doi: 10.1016\/j.ejvs.2017.06.023.","DOI":"10.1016\/j.ejvs.2017.06.023"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","unstructured":"van Vuuren TMAJ Doganci S Wittens CHA. Patency rates and clinical outcomes in a cohort of 200 patients treated with a dedicated venous stent. J Vasc Surg Venous Lymphat Disord. 2018;6(3):321\u2013329. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29396156&query_hl=1. doi: 10.1016\/j.jvsv.2017.09.013.","DOI":"10.1016\/j.jvsv.2017.09.013"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","unstructured":"Jiang L Zhuang H Song T Li X. Clinical outcomes at 3 years after stenting for thrombotic and non-thrombotic iliac vein compression syndrome patients. Clin Appl Thromb Hemost. 2024;30:10760296231220053. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=38213124&query_hl=1. doi: 10.1177\/10760296231220053.","DOI":"10.1177\/10760296231220053"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","unstructured":"Hong L Wang X Fang Z et al. Editor\u2019s choice\u2013clinical efficacy of venastent\u2013a novel iliac vein stent for non-thrombotic iliac vein lesions: a multi-centre randomised controlled trial. Eur J Vasc Endovasc Surg. 2022;63(6):883\u2013889. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35717357&query_hl=1. doi: 10.1016\/j.ejvs.2022.04.005.","DOI":"10.1016\/j.ejvs.2022.04.005"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","unstructured":"Wu Z He K Peng X Lin W. Endovascular therapy for iliac vein compression syndrome: superior outcomes in non-thrombotic patients and risk factors for stent restenosis. Am J Transl Res. 2025;17(5):3521\u20133529. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=40535660&query_hl=1. doi: 10.62347\/PAOE4803.","DOI":"10.62347\/PAOE4803"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","unstructured":"Pinz\u00f3n-Pinto M Portilla-Rojas E Ebratt A et al. Outcomes in endovascular management of may thurner syndrome without access to IVUS in a Latin American cohort: a retrospective study. Vasc Endovascular Surg. 2025;59(7):690\u2013694. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=40570544&query_hl=1. doi: 10.1177\/15385744251355218.","DOI":"10.1177\/15385744251355218"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","unstructured":"Morris RI Jackson N Khan T et al. Performance of open and closed cell laser cut nitinol stents for the treatment of chronic iliofemoral venous outflow obstruction in patients treated at a single centre. Eur J Vasc Endovasc Surg. 2022;63(4):613\u2013621. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35027274&query_hl=1. doi: 10.1016\/j.ejvs.2021.10.052.","DOI":"10.1016\/j.ejvs.2021.10.052"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","unstructured":"Piao L Barbati ME Shekarchian S et al. Comparison of endovascular strategy versus hybrid procedure in treatment of chronic venous obstructions involving the confluence of common femoral vein. J Vasc Surg Venous Lymphat Disord. 2022;10(2):334\u2013341. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34478907&query_hl=1. doi: 10.1016\/j.jvsv.2021.08.016.","DOI":"10.1016\/j.jvsv.2021.08.016"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","unstructured":"Powell T Raju S Jayaraj A. Comparison between a dedicated venous stent and standard composite wallstent-z stent approach to iliofemoral venous stenting: intermediate-term outcomes. J Vasc Surg Venous Lymphat Disord. 2023;11(1):82\u201390. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=35872144&query_hl=1. doi: 10.1016\/j.jvsv.2022.05.012.","DOI":"10.1016\/j.jvsv.2022.05.012"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","unstructured":"Lichtenberg MKW de Graaf R Stahlhoff WF \u00d6zkapi A Rassaf T Breuckmann F. Venovo venous stent in the treatment of non-thrombotic or post-thrombotic iliac vein lesions \u2013 short-term results from the Arnsberg Venous Registry. VASA. 2019;48(2):175\u2013180. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=30451095&query_hl=1. doi: 10.1024\/0301-1526\/a000763.","DOI":"10.1024\/0301-1526\/a000763"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","unstructured":"Razavi M Marston W Black S Bentley D Negl\u00e9n P. The initial report on 1-year outcomes of the feasibility study of the VENITI VICI VENOUS STENT in symptomatic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2018;6(2):192\u2013200. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29290601&query_hl=1. doi: 10.1016\/j.jvsv.2017.10.014.","DOI":"10.1016\/j.jvsv.2017.10.014"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","unstructured":"Razavi MK Black S Gagne P Chiacchierini R Nicolini P Marston W. Pivotal study of endovenous stent placement for symptomatic iliofemoral venous obstruction. Circ Cardiovasc Interv. 2019;12(12):e008268. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31833414&query_hl=1. doi: 10.1161\/CIRCINTERVENTIONS.119.008268.","DOI":"10.1161\/CIRCINTERVENTIONS.119.008268"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","unstructured":"Razavi MK Jaff MR Miller LE. Safety and effectiveness of stent placement for iliofemoral venous outflow obstruction: systematic review and meta-analysis. Circ Cardiovasc Interv. 2015;8(10):e002772. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26438686&query_hl=1. doi: 10.1161\/CIRCINTERVENTIONS.115.002772.","DOI":"10.1161\/CIRCINTERVENTIONS.115.002772"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","unstructured":"Negl\u00e9n P Hollis KC Olivier J Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome clinical and hemodynamic result. J Vasc Surg. 2007;46(5):979\u2013990. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17980284&query_hl=1. doi: 10.1016\/j.jvs.2007.06.046.","DOI":"10.1016\/j.jvs.2007.06.046"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","unstructured":"Raju S Negl\u00e9n P. Percutaneous recanalization of total occlusions of the iliac vein. J Vasc Surg. 2009;50(2):360\u2013368. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19446993&query_hl=1. doi: 10.1016\/j.jvs.2009.01.061.","DOI":"10.1016\/j.jvs.2009.01.061"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","unstructured":"Kingdon J Gwozdz AM Morris R Black SA Smith A Saha P. Device profile of the Vici Venous Stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy. Expert Rev Med Devices. 2020;17(5):391\u2013397. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=32223356&query_hl=1. doi: 10.1080\/17434440.2020.1748009.","DOI":"10.1080\/17434440.2020.1748009"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","unstructured":"Taha MAH Busuttil A Bootun R et al. A clinical guide to deep venous stenting for chronic iliofemoral venous obstruction. J Vasc Surg Venous Lymphat Disord. 2022;10(1):258\u2013266. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34020107&query_hl=1. doi: 10.1016\/j.jvsv.2020.12.087.","DOI":"10.1016\/j.jvsv.2020.12.087"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","unstructured":"O\u2019Sullivan GJ Karunanithy N Binkert CA Ortega MR Lichtenberg M McCann-Brown JA. One year outcomes of the VIVO-EU study of treatment of symptomatic iliofemoral outflow obstruction with the Zilver Vena venous self-expanding stent. Cardiovasc Intervent Radiol. 2021;44(12):1930\u20131936. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34611732&query_hl=1. doi: 10.1007\/s00270-021-02969-0.","DOI":"10.1007\/s00270-021-02969-0"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","unstructured":"Dake MD O\u2019Sullivan G Shammas NW Lichtenberg M Mwipatayi BP Settlage RA. Three-year results from the venovo venous stent study for the treatment of iliac and femoral vein obstruction. Cardiovasc Intervent Radiol. 2021;44(12):1918\u20131929. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34545448&query_hl=1. doi: 10.1007\/s00270-021-02975-2.","DOI":"10.1007\/s00270-021-02975-2"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","unstructured":"Barco S Jalaie H Sebastian T et al. Aspirin plus rivaroxaban versus rivaroxaban alone for the prevention of venous stent thrombosis among patients with post-thrombotic syndrome: the multicenter multinational randomized open-label ARIVA trial. Circulation. 2025;25151(12):835\u2013846. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=39874026&query_hl=1. doi: 10.1161\/CIRCULATIONAHA.124.073050.","DOI":"10.1161\/CIRCULATIONAHA.124.073050"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","unstructured":"Gagne PJ Gasparis A Black S et al. Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial. J Vasc Surg Venous Lymphat Disord. 2018;6(1):48\u201356. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=29033314&query_hl=1. doi: 10.1016\/j.jvsv.2017.07.009.","DOI":"10.1016\/j.jvsv.2017.07.009"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","unstructured":"Gagne PJ Tahara RW Fastabend CP et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord. 2017;5(5):678\u2013687. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=28818221&query_hl=1. doi: 10.1016\/j.jvsv.2017.04.007.","DOI":"10.1016\/j.jvsv.2017.04.007"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","unstructured":"Bravo E Tempesta D Viault N. Improving pre- and post-IR procedure experience: what the anesthesiologists can offer. Cardiovasc Intervent Radiol. 2025;48(7):970\u2013975. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=39966161&query_hl=1. doi: 10.1007\/s00270-025-03960-9.","DOI":"10.1007\/s00270-025-03960-9"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","unstructured":"Feldman A. Anesthesia and analgesia for interventional radiology. Tech Vasc Interv Radiol. 2025;28(2):101037. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=40634054&query_hl=1. doi: 10.1016\/j.tvir.2025.101037.","DOI":"10.1016\/j.tvir.2025.101037"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","unstructured":"Knuttinen M Machan L Khilnani NM et al. Diagnosis and management of pelvic venous disorders: AJR expert panel narrative review. AJR Am J Roentgenol. 2023;221(5):565\u2013574. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=37095667&query_hl=1. doi: 10.2214\/AJR.22.28796.","DOI":"10.2214\/AJR.22.28796"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","unstructured":"Aurshina A Ostrozhynskyy Y Nguyen H et al. Is it necessary to dilate stents in management of non-thrombotic iliac vein lesions. ? J Vasc Surg Venous Lymphat Disord. 2019;7(4):522\u2013526. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=31203858&query_hl=1. doi: 10.1016\/j.jvsv.2018.11.008.","DOI":"10.1016\/j.jvsv.2018.11.008"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","unstructured":"Langwieser N Bernlochner I Wustrow I et al. Combination of factor Xa inhibition and antiplatelet therapy after stenting in patients with iliofemoral post-thrombotic venous obstruction. Phlebology. 2016;31(6):430\u2013437. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=26183668&query_hl=1. doi: 10.1177\/0268355515596289.","DOI":"10.1177\/0268355515596289"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","unstructured":"Raffetto JD Ligi D Maniscalco R Khalil RA Mannello F. Why venous leg ulcers have difficulty healing: overview on pathophysiology clinical consequences and treatment. J Clin Med. 2020;10(1). http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33374372&query_hl=1. doi: 10.3390\/jcm10010029.","DOI":"10.3390\/jcm10010029"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","unstructured":"Marston W Fish D Unger J Keagy B. Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers. J Vasc Surg. 2011;53(5):1303\u20131308. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21215568&query_hl=1. doi: 10.1016\/j.jvs.2010.10.120.","DOI":"10.1016\/j.jvs.2010.10.120"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","unstructured":"Aherne TM Keohane C Mullins M et al. DEep VEin lesion OPtimisation (DEVELOP) trial: protocol for a randomised assessor-blinded feasibility trial of iliac vein intervention for venous leg ulcers. Pilot Feasibility Stud. 2021;7(1):42. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=33541436&query_hl=1. doi: 10.1186\/s40814-021-00779-2.","DOI":"10.1186\/s40814-021-00779-2"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","unstructured":"Maleti O Perrin M. Reconstructive surgery for deep vein reflux in the lower limbs: techniques results and indications. Eur J Vasc Endovasc Surg. 2011;41(6):837\u2013848. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=21454106&query_hl=1. doi: 10.1016\/j.ejvs.2011.02.013.","DOI":"10.1016\/j.ejvs.2011.02.013"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","unstructured":"Liu D Zhao H Zhang J Zhao L Wu Y. Single-leaflet reconstruction surgery for severe chronic lower limb venous insufficiency caused by post-thrombotic syndrome: a case report and literature review. Thromb J. 2025;23(1):64. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=40524164&query_hl=1. doi: 10.1186\/s12959-025-00752-6.","DOI":"10.1186\/s12959-025-00752-6"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","unstructured":"Cifuentes S Ulloa JH Rasmussen TE. An implantable bioprosthetic venous valve to establish deep vein competence for post-thrombotic syndrome. JAMA Surg. 2023;158(3):316\u2013317. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=36652222&query_hl=1. doi: 10.1001\/jamasurg.2022.6362.","DOI":"10.1001\/jamasurg.2022.6362"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","unstructured":"Maleti O Orso M Lugli M Perrin M. Systematic review and meta-analysis of deep venous reflux correction in chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2023;11(6):1265\u20131275. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=37453548&query_hl=1. doi: 10.1016\/j.jvsv.2023.07.003.","DOI":"10.1016\/j.jvsv.2023.07.003"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","unstructured":"Li M Wang S Zhao J Li C Yan Y Shi C. Iliac vein stenting outcomes in non-thrombotic and thrombotic diseases: a systematic review and meta-analysis. Biomol Biomed. 2025. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=41090385&query_hl=1. doi: 10.17305\/bb.2025.12777.","DOI":"10.17305\/bb.2025.12777"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","unstructured":"Majeed GM Lodhia K Carter J et al. A systematic review and meta-analysis of 12-month patency after intervention for iliofemoral obstruction using dedicated or non-dedicated venous stents. J Endovasc Ther. 2022;29(3):478\u2013492. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=34758673&query_hl=1. doi: 10.1177\/15266028211057085.","DOI":"10.1177\/15266028211057085"},{"key":"e_1_3_3_86_2","doi-asserted-by":"crossref","unstructured":"Daugherty SF Gillespie DL. Venous angioplasty and stenting improve pelvic congestion syndrome caused by venous outflow obstruction. J Vasc Surg Venous Lymphat Disord. 2015;3(3):283\u2013289. http:\/\/dx.doi.org\/10.1016\/j.jvsv.2015.01.003.","DOI":"10.1016\/j.jvsv.2015.01.003"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","unstructured":"Villalba L Larkin T. Iliac venous stenting provides long-term relief from chronic pelvic pain. J Vasc Surg Venous Lymphat Disord. 2025;13(1):101993. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213333X2400413X; https:\/\/api.elsevier.com\/content\/article\/PII:S2213333X2400413X?httpAccept=text\/xml. doi: 10.1016\/j.jvsv.2024.101993.","DOI":"10.1016\/j.jvsv.2024.101993"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","unstructured":"Gavrilov SG Lebedev IS Vasilyev AV Churikov DA Mishakina NY Alenichev AV. Prospective cohort study of a treatment strategy for a combination of the left common iliac vein compression stenosis and pelvic venous insufficiency. J Endovasc Ther. 2024:15266028241271736. https:\/\/pubmed.ncbi.nlm.nih.gov\/39155600\/. doi: 10.1177\/15266028241271736.","DOI":"10.1177\/15266028241271736"},{"key":"e_1_3_3_89_2","doi-asserted-by":"crossref","unstructured":"Gavrilov SG Vasilyev AV Krasavin GV Moskalenko YP Mishakina NY. Endovascular interventions in the treatment of pelvic congestion syndrome caused by may-thurner syndrome. J Vasc Surg Venous Lymphat Disord. 2020;8(6):1049\u20131057. http:\/\/dx.doi.org\/10.1016\/j.jvsv.2020.02.012.","DOI":"10.1016\/j.jvsv.2020.02.012"},{"key":"e_1_3_3_90_2","doi-asserted-by":"crossref","unstructured":"Lakhanpal G Kennedy R Lakhanpal S Sulakvelidze L Pappas PJ. Pelvic venous insufficiency secondary to iliac vein stenosis and ovarian vein reflux treated with iliac vein stenting alone. J Vasc Surg Venous Lymphat Disord. 2021;9(5):1193\u20131198. http:\/\/dx.doi.org\/10.1016\/j.jvsv.2021.03.006.","DOI":"10.1016\/j.jvsv.2021.03.006"},{"key":"e_1_3_3_91_2","doi-asserted-by":"crossref","unstructured":"Santoshi RKN Lakhanpal S Satwah V Lakhanpal G Malone M Pappas PJ. Iliac vein stenosis is an underdiagnosed cause of pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2018;6(2):202\u2013211. http:\/\/dx.doi.org\/10.1016\/j.jvsv.2017.09.007.","DOI":"10.1016\/j.jvsv.2017.09.007"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028261453257","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15266028261453257","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15266028261453257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:47:23Z","timestamp":1780674443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15266028261453257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":90,"alternative-id":["10.1177\/15266028261453257"],"URL":"https:\/\/doi.org\/10.1177\/15266028261453257","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"article-number":"15266028261453257"}}